Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;10(5):981-999.
doi: 10.1016/j.jacep.2023.12.009. Epub 2024 Feb 21.

Ventricular Tachycardia Ablation Endpoints: Moving Beyond Noninducibility

Affiliations
Free article
Review

Ventricular Tachycardia Ablation Endpoints: Moving Beyond Noninducibility

Pasquale Santangeli et al. JACC Clin Electrophysiol. 2024 May.
Free article

Abstract

In patients with structural heart disease and ventricular tachycardia (VT) undergoing catheter ablation, the response to programmed electrical stimulation (PES) at the end of the procedure has been traditionally used to evaluate the acute success and predict long-term outcomes. Although noninducibility at PES has been extensively investigated and validated in clinical trials and large multicenter registries, its performance in predicting long-term freedom from VT is suboptimal. In addition, PES has inherent limitations related to the influence of background antiarrhythmic drug therapy, periprocedural use of anesthesia, and the heterogeneity in PES protocols. The increased utilization of substrate-based ablation approaches that focus on ablation of abnormal electrograms identified with mapping in sinus or paced rhythm has been paralleled by a need for additional procedural endpoints beyond VT noninducibility at PES. This article critically appraises the relative merits and limitations of different procedural endpoints according to different ablation techniques for catheter ablation of scar-related VT.

Keywords: VT noninducibility; catheter ablation; endpoints; substrate ablation; ventricular tachycardia.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures Funded in part by the William and Kristin Loomis Donation to the Cleveland Clinic Electrophysiology Research Fund. Dr Santangeli is a consultant for Biosense Webster, Abbott, Boston Scientific, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

MeSH terms

LinkOut - more resources